KJ Williams, EA Fisher - Current Opinion in Clinical Nutrition & Metabolic Care, 2005 - journals.lww.com Purpose of review: Paradoxically, many well-established components of the
heart-healthy lifestyle are pro-oxidant, including polyunsaturated fat and
moderate alcohol consumption. Moreover, antioxidant supplements have failed ... Cited by 39 - Related articles - All 6 versions
AP Levy, JE Levy, S Kalet-Litman, R Miller- … - Arteriosclerosis Thrombosis and Vascular Biology, 2007 - Am Heart Assoc Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams &
Wilkins, a division of Wolters ... Haptoglobin Genotype Is a Determinant ... Cited by 40 - Related articles - All 9 versions
- ►ahajournals.org U Milman, S Blum, C Shapira, D Aronson, R … - Arteriosclerosis, Thrombosis, and Vascular Biology, 2008 - Am Heart Assoc Objective— Clinical trials of vitamin E have failed to demonstrate a decrease
in cardiovascular events. However, these studies did not address possible
benefit to subgroups with increased oxidative stress. Haptoglobin (Hp), a ... Cited by 34 - Related articles - All 5 versions
MJ McQueen, E Lonn, HC Gerstein, J Bosch, … - Scandinavian Journal of Clinical & Laboratory …, 2005 - informahealthcare.com The HOPE study was a 19 country, prospective randomized trial in which the
ACE‐inhibitor Ramipril but not Vitamin E significantly reduced the risk of
future cardiovascular events in a high‐risk population of men and women, ... Cited by 17 - Related articles - BL Direct - All 7 versions
AP Levy - Pharmacology and Therapeutics, 2006 - Elsevier Atherosclerotic cardiovascular disease (CVD) and diabetic vascular disease have
been associated with an increase in oxidative stress. Mechanistic studies in
vitro and in animals have demonstrated a direct role for oxidatively ... Cited by 17 - Related articles - All 6 versions
- ►diabetesjournals.org R Asleh, S Blum, S Kalet-Litman, J Alshiek, R … - Diabetes, 2008 - Am Diabetes Assoc OBJECTIVE—Pharmacogenomics is a key component of personalized medicine. The
Israel Cardiovascular Events Reduction with Vitamin E Study, a prospective
placebo-controlled study, recently demonstrated that vitamin E could ... Cited by 14 - Related articles - All 4 versions
T Costacou, RE Ferrell, TJ Orchard - Diabetes, 2008 - Am Diabetes Assoc RESULTS—The proportions of the cohort with the haptoglobin 1/1, 2/1, and 2/2
genotypes were 11.5, 41.3, and 47.2%, respectively. During 18 years of
follow-up, there were 135 (29.8%) incident CAD events. Univariately, the ... Cited by 10 - Related articles - All 4 versions
- ►nih.gov CA Gleissner, E Galkina, JL Nadler, K Ley - Drug Discovery Today: Disease Mechanisms, 2007 - Elsevier Diabetes mellitus is one of the major risk factors for atherosclerosis, an
inflammatory disease of the arterial wall, in which leukocytes and oxidized
lipoproteins accumulate leading to formation of fatty streaks and ... Cited by 7 - Related articles - All 3 versions
R Miller-Lotan, B Miller, F Nakhoul, D … - Diabetes/Metabolism Reviews - interscience.wiley.com It is also possible that your web browser is not configured or not able to
display style sheets. In this case, although the visual presentation will be
degraded, the site should continue to be functional. We recommend using the ... Cited by 7 - Related articles - BL Direct - All 3 versions
